The FDA has awarded De Novo certification to NigthWare which has developed a digital therapy to combat sleep disorders.
machine learning
The UK drug agency will use IA to detect the adverse effects of vaccines for Covid-19
The Medicines and Healthcare Regulatory Authority (MHRA) held a tender to entrust the development of a system based on artificial intelligence.
A CDSS that predicts the complications of Covid-19
The FDA has issued an Emergency Use Authorization (EUA) to a Clinical Decision Support System (CDSS) that provides when an adult patient hospitalized with COVID-19 is at risk of further complications.
